Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Screening for ovarian cancer.

Cleola Anderiesz1, Michael A Quinn

  • 1National Cancer Control Initiative, Carlton, VIC, Australia.

The Medical Journal of Australia
|June 12, 2003
PubMed
Summary

Ovarian cancer is a leading cause of gynecological cancer death. Annual screening with CA 125 blood tests and transvaginal ultrasounds is recommended for high-risk women.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Olaparib, durvalumab, and cyclophosphamide, and a prognostic blood signature in platinum-sensitive ovarian cancer: the randomized phase 2 SOLACE2 trial.

Nature communications·2025
Same author

Combining TNFR2-Expressing Tregs and IL-6 as Superior Diagnostic Biomarkers for High-Grade Serous Ovarian Cancer Masses.

Cancers·2023
Same author

Conceptual Framework for Cancer Care During a Pandemic Incorporating Evidence From the COVID-19 Pandemic.

JCO global oncology·2022
Same author

Cancer Australia consensus statement on COVID-19 and cancer care: embedding high value changes in practice.

The Medical journal of Australia·2021
Same author

Overdiagnosis of screen-detected breast cancer.

The Medical journal of Australia·2021
Same author

The IGCS global curriculum mentorship and training program: building human capacity for gynecologic cancer treatment and research where the need is greatest.

International journal of gynecological cancer : official journal of the International Gynecological Cancer Society·2021

Area of Science:

  • Gynecologic Oncology
  • Medical Screening
  • Cancer Diagnostics

Background:

  • Ovarian cancer is the leading cause of death among gynecological malignancies.
  • No precancerous lesions have been identified for ovarian cancer.
  • Bimanual pelvic examination lacks proven value as a screening test for ovarian cancer.

Purpose of the Study:

  • To evaluate the effectiveness of screening methods for ovarian cancer.
  • To determine optimal screening strategies for women at high risk of ovarian cancer.

Main Methods:

  • Transvaginal ultrasound examination is under evaluation for population screening.
  • Measurement of cancer antigen 125 (CA 125) levels is used in conjunction with imaging.
  • Annual screening protocols for high-risk individuals include CA 125 measurement and transvaginal ultrasound.

Main Results:

  • Transvaginal ultrasound, with or without CA 125 level measurement, is being evaluated for population screening.
  • Current evidence does not support bimanual examination as an effective screening tool.
  • Annual screening is advised for women at high risk.

Conclusions:

  • Ovarian cancer screening remains an area of active research and evaluation.
  • High-risk women benefit from annual screening using CA 125 and transvaginal ultrasound.
  • Further research is needed to identify precancerous lesions and improve early detection of ovarian cancer.

Related Experiment Videos